Recent Material Events - Targacept, Inc (TRGT)

Filing Date	Description
2008-09-16	On a conference call held by Targacept, Inc. on September 15, 2008 to discuss the results of a Phase 2b clinical trial of AZD3480 in mild to moderate Alzheimer’s disease, a Targacept official inadvertently stated in response to a question from a ...
2008-05-06	The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabi ...
2008-01-18	The Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K, and the description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit. The Company is also filing the l ...
2008-01-04	On January 3, 2008, the Compensation Committee took the following actions with respect to the program: ...
2007-12-10	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2007-12-04	As a result of her election to the Board, Ms. Brown is eligible to receive cash and equity compensation commensurate with that paid to other non-employee directors under the Company’s non-employee director compensation program. Initially, Ms. Br ...
2007-12-03	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2007-02-22	The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the l... ...
2007-01-26	• Exclusive License Agreement (the “License Agreement”) by and between the Company and Yale University (“Yale”);... ...
2007-01-16	(e) Targacept, Inc. (the “Company”) maintains an incentive award program (the “Program”) under which all of its employees, including its principal executive officer, principal financial officer and other named executive officers,... ...